Classification of malignant/benign groups in lung cancer by machine learning and investigation of feature significance of parameters
BIOMEDICAL ENGINEERING-BIOMEDIZINISCHE TECHNIK, 2026 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Basım Tarihi: 2026
- Doi Numarası: 10.1515/bmt-2024-0628
- Dergi Adı: BIOMEDICAL ENGINEERING-BIOMEDIZINISCHE TECHNIK
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, Compendex, EMBASE, INSPEC, MEDLINE, Biomedical Reference Collection: Corporate Edition (EBSCO), Engineering Source (EBSCO)
- İstanbul Üniversitesi Adresli: Evet
Özet
Objectives This study aimed to apply machine learning (ML) models to enhance lung cancer (LC) classification, distinguishing malignant from benign tumors, using data from 73 patients.Methods The dataset included PET/CT biomarkers and demographic factors, with SMOTE applied to address class imbalance. Three models were evaluated using 10-fold cross-validation to compare Random Forest (RF), Decision Tree (DT), Extra Trees Classifier (ETC), and XGBoost algorithms based on accuracy and AUC.Results ETC performed best in Model 1 (86 % accuracy, AUC 0.95), RF in Model 2 (94 % accuracy, AUC 0.97), and XGBoost in Model 3 (94 % accuracy, AUC 0.98). XGBoost consistently outperformed others, particularly in Model 3, which included age and smoking. Feature importance analysis highlighted SUVmax as the most predictive variable, with smoking having a moderate influence and gender being minimal.Conclusions Integrating clinical and lifestyle data with PET/CT parameters significantly improved LC classification. XGBoost emerged as the most effective model, demonstrating that comprehensive models enhance diagnostic accuracy beyond traditional metrics.